Back To Upcoming Events
About the Event
The FDA is hosting a virtual public webinar titled “Informed Consent—More than Just Another Document to Sign?” on November 8, 2024, from 2:00 p.m. to 3:00 p.m. ET. Organized by the Office of the Chief Medical Officer’s Office of Clinical Policy and the Office of External Affairs’ Public Engagement Staff, this event will focus on the vital role of informed consent in clinical research.
Informed consent ensures that individuals who volunteer for clinical trials fully understand the purpose, risks, and benefits before participating. This webinar will provide an overview of the FDA’s expectations for informed consent and discuss improvements to make consent materials clearer and more understandable for participants.
Key Topics
- The purpose of informed consent in FDA-regulated trials
- Critical components of informed consent documents and oral discussions
- FDA’s expectations for the informed consent process
Speakers
- Ann Meeker-O’Connell, MS, Director, Office of Clinical Policy
- Suzanne Pattee, JD, Regulatory Counsel, Office of Clinical Policy
Registration
This webinar is free and open to the public. Registration is required and will remain open until the event begins. Registrants can submit questions for the speakers both before and during the event. Visit the event page for the registration link.
